Warehouse, Storage and Transport Requirements

Updated: 2026-11-12 · GRZAN Regulatory Team · Verification date 2026-10-20

1. Key takeaways

In Saudi Arabia, storage and transport conditions are not logistics details but substantive content of licensing and inspection: MDS-REQ 12 (Transportation and Storage) sets storage and transport requirements, MDS-REQ 9 V1.0 (2022-07-31) brings site conditions into the scope of the MDEL (Medical Device Establishment License) review, and MDS-REQ 10 V1.0 (2022-06-22) governs inspection execution. Frequent findings concentrate on four areas: temperature and humidity monitoring and records, zoned storage and status labelling, physical segregation of recalled and nonconforming products, and expiry rotation. MDS-G030 V1.0 lists storage and transport requirements related to temperature and humidity control among the Saudi-specific applicable requirements under the reliance pathway, so reliance projects cannot cut corners here either. The practical estimate of the MDEL fee is SAR 5,000 to 25,000 plus 15% VAT, and site renovation investment usually needs its own budget line.

  • Continuous monitoring data, not the presence of air conditioning, is what counts as a compliance record.
  • Five storage zones by status, with recall and nonconforming stock physically segregated.
  • FEFO expiry rotation, system interception of expired batches and destruction records.
  • Carrier responsibilities for temperature records must be written into quality agreements.
  • Storage and transport is a Saudi-specific requirement under the reliance pathway (MDS-G030 V1.0), including SBC Part 401 electrical provisions.

2. Legal basis

The table below lists the instruments cited for storage and transport. Items marked as a practical estimate are pending verification against the SFDA website and GHAD billing.

RegulationReferencePublication dateProvisionKey point
MDS-REQ 12 Transportation and StorageVersion and reference not officially confirmed [practical estimate]No official version date [practical estimate]No provision number [practical estimate]Requirements for medical device transport and storage; verification: search the SFDA website for the current MDS-REQ 12 version and date and check the provisions
MDS-REQ 9 Requirements for Licensing of Medical Devices EstablishmentsV1.0, reference MDS-REQ-009-V1/2207312022-07-31Specific article numbers not compiled item by item [practical estimate]Establishment licence conditions including premises and facilities; verification: download the current version and check the premises condition provisions
MDS-REQ 10 Requirements for Inspections and Quality Management System for Medical DevicesV1.0, reference MDS-REQ-010-V1/2206222022-06-22Specific article numbers not compiled item by item [practical estimate]Inspection and QMS requirements; verification: download the current version and check inspection and nonconformity handling provisions
MDS-G030 SFDA Reliance Approach for Medical DeviceV1.0, reference MDS-G-030-V1/2609092026-09-09General Eligibility Criteria (Saudi-specific applicable requirements)Saudi-specific applicable requirements must be met; official examples include storage and transport requirements related to temperature and humidity control, labelling and language, and Saudi Building Code Part 401
MDS-REQ 11 Requirements for Post-Market Surveillance of Medical DevicesV2.0, reference MDS-REQ-011-V2/2303232023-03-23Section 1 Scope item 7After-sales and maintenance services are one of the eight post-market surveillance scope items
MDEL fee rangeNo official fee schedule reference [practical estimate]No official publication date [practical estimate]No provision number [practical estimate]SAR 5,000 to 25,000; verification: the GHAD billing statement prevails

3. Expert insights

1. Air conditioning is not a compliance record; continuous monitoring data is. Saudi Arabia’s heat makes temperature and humidity control the first gateway of any storage and transport review. Inspectors look not for air conditioning or a cold room, but for whether monitoring points cover the least favourable locations, whether records are continuous and exportable, whether excursions trigger alarms with documented handling, and whether outages and equipment failures have contingency plans and drill records. The typical situation GRZAN meets in site coaching is full equipment with broken records: paper logs blank over weekends, electronic records without alarms, calibration certificates expired. Fixing such problems costs far less than remediating a nonconformity and being re-inspected, so run a mock inspection before the MDEL application.

2. Zoned storage and status labelling answer one question: can this box be shipped now? Quarantine, accepted, nonconforming, returned and recall segregation, five statuses must have physical zones and clear labels, with records behind every transition. The easiest place to lose points is segregation of recalls and nonconforming stock: many warehouses pile them in a corner of the accepted zone with a handwritten sign, unable to prove at inspection they will not ship by mistake. Another frequent finding is expiry rotation: whether the first-expiry-first-out (FEFO) rule is in procedures, whether the system hard-blocks expired batches, and whether expired goods have a sealed area and destruction records. MDS-REQ 11 V2.0 places destruction of waste medical devices within post-market surveillance, so destruction cannot rest on a single internal form.

3. Responsibilities in the transport leg must be written into contracts. The typical transport risk is a responsibility vacuum: while goods sit on the carrier’s truck, in the port yard or in last-mile delivery, who monitors temperature, who keeps the data, and who decides on handling when limits are exceeded. State in the quality agreement that carriers must provide continuous temperature records and hand over the data on arrival, that receivers check records before warehouse release, and that out-of-limit batches enter the quarantine area for evaluation under set procedures. For cold chain products, validate the packaging for hold time under worst-case conditions, because Saudi extremes will defeat packaging designed for routine routes.

4. Storage and transport is a Saudi-specific requirement under reliance and cannot be covered by overseas data. Of the four general eligibility criteria in MDS-G030 V1.0, the third, meeting Saudi-specific applicable requirements, explicitly cites by example storage and transport requirements related to temperature and humidity control, Part 401 of the Saudi Building Code on supply voltage, frequency and insulation colours of conductors, and the content and language of labels, instructions for use and user interfaces. The practical meaning: even where a product is already approved by the TGA, Health Canada, the EEA, the PMDA, the MHRA or the FDA and technically identical, its fit for the Saudi environment needs separate justification. GRZAN considers this the item Chinese manufacturers most often underestimate: it does not deepen the technical review, but it demands validation data for Saudi conditions, such as high-temperature storage stability, power adaptation and Arabic interfaces.

For the establishment licence’s activity scope, see https://www.grzan.cn/regulations/saudi/medical-device-establishment-licence-34 ; for destruction and after-sales duties, see https://www.grzan.cn/regulations/saudi/post-market-surveillance-ncmdr-and-saudi-vigilance-41 .

4. Practical recommendations

  • Run a mock inspection first: self-check temperature and humidity records, zone labelling, recall segregation and expiry rotation, producing a corrective action list with owners.
  • Place monitoring points: cover the least favourable positions (near doors and windows, top floors, cold room return air), keep records continuous and exportable, and close the loop on excursion alarms.
  • Calibration and maintenance: calibrate sensors and refrigeration equipment on schedule, with certificates in validity and archived.
  • Status zoning: set five physical areas for quarantine, accepted, nonconforming, returned and recall segregation, record every transition, never mixing recalled with accepted stock.
  • Expiry management: write FEFO into procedures, block expired batches in the system, and keep separate sealed storage and destruction records for expired goods.
  • Carrier management: quality agreements to state continuous temperature records, data handover, excursion handling and receiver checks before release, with cold chain packaging validated for worst-case conditions.
  • Power and environmental adaptation: check supply voltage, frequency and conductor insulation colours against SBC Part 401; on the reliance pathway, argue storage and transport in the application.
  • Budget and advice: estimate MDEL costs across the SAR 5,000 to 25,000 range (practical estimate, plus 15% VAT), listing site renovation and equipment separately; direct questions to SFDA free channels, call centre 19999 and md.rs@sfda.gov.sa.

5. Verification checklist

  • □ Current MDS-REQ 12 downloaded and storage and transport requirements compared item by item (practical estimate, pending verification)
  • □ Temperature and humidity monitoring points cover the least favourable positions, records continuous, exportable, with excursion alarms
  • □ Sensors and refrigeration equipment within calibration validity, certificates archived
  • □ Quarantine, accepted, nonconforming, returned and recall segregation physically separated and clearly labelled
  • □ Recalled and nonconforming stock in separate sealed areas, risk of mistaken shipment excluded
  • □ FEFO rule written into procedures and the system able to block expired batches
  • □ Destruction of expired and waste devices has sealed storage and destruction records
  • □ Carrier quality agreements include continuous temperature records, data handover and excursion handling clauses
  • □ Cold chain packaging validated against Saudi extreme temperature conditions
  • □ Reliance pathway projects argue storage, transport and power adaptation in the application (SBC Part 401)

Regulatory information verified as of 29 October 2026.

How GRZAN can help. GRZAN provides medical device and IVD registration, quality system, authorised representative and local testing support for the Saudi Arabian market. Our team coordinates Saudi Authorized Representative arrangements, import licences, and supports post-market vigilance obligations. Business enquiries: info@grzanglobal.com

Disclaimer

Prepared by GRZAN from publicly available regulation. It is provided for general information only and does not constitute legal advice. Legislation and official fees are subject to change by the competent authority.

About GRZAN

GRZAN (Global Regulatory Zone Access Navigator) — the global market-access navigator for medical devices and IVDs.

GRZAN is a specialist consultancy for medical device and IVD market access, providing end-to-end regulatory solutions across the product lifecycle and making international market entry simpler and faster.

Key figures. More than 25 wholly owned subsidiaries worldwide covering 50+ countries and regions; chosen by 100+ listed and leading Chinese device manufacturers, with 4,000+ successful cases; 12+ years in the sector and 200+ regulatory training sessions and seminars delivered.

What we do. Global market access: multi-country registration programmes, technical documentation, regulatory advice. Clinical evidence: clinical evaluation reports (CER), usability studies, overseas clinical investigations. Quality systems: ISO 13485, MDSAP, FDA QMSR and BGMP implementation and audit readiness. Authorised representative and licence-holder services across Southeast Asia, Latin America, the Middle East, Africa, Europe and North America.

Why GRZAN. A real operating entity, with the certificate held by the manufacturer: our direct overseas subsidiaries act as the compliant local holder, so the regulatory relationship stays clear and you keep control rather than being tied to a distributor. Direct access to the team: no time-zone gap, no language barrier, no cultural gap. Review points anticipated: we know what FDA 510(k), EU MDR, Southeast Asian, Latin American and Middle Eastern reviewers look for, which shortens timelines and reduces deficiency letters. Pathway planning: pre-decision analysis and risk assessment before you commit.

Every engagement rests on three commitments: efficiency through pre-submission review, certainty through a clear pathway, and stability through a licence-holder that stays in place.

Take your devices global with GRZAN

We work with manufacturers worldwide to open new markets with a clear regulatory pathway.

Contact us
WhatsApp
QR Code
WhatsApp QR Code
Scan to chat on WhatsApp
Phone
Call
Office Mon-Fri 9:00-18:00
0755-88659477
Mobile 24/7 Service
+86 15816864648
Email
Mail